ArticleFrontiers in immunology2022

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.

Thi-Anh-Thuy Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.